Francesco Papi

Francesco Papi

Auto-generated profile, based on publicly available information

Francesco Papi

Electron Crystallography, Center for Materials Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
CBCarla Bazzicalupi
Carla Bazzicalupi
MFMarta Ferraroni
Marta Ferraroni
FPFrancesco Papi
Francesco Papi
LMLara Massai
Lara Massai
BBBenoît Bertrand
Benoît Bertrand
ACAngela Casini
Angela Casini
The dicarbene gold(I) complex [Au(9‐methylcaffein‐8‐ylidene)2]BF4 is an exceptional organometallic compound of profound interest as a prospective anticancer agent. This gold(I) complex was previously reported to be highly cytotoxic toward various cancer cell lines in vitro and behaves as a selective G‐quadruplex stabilizer. Interactions of the gold complex with various telomeric DNA models have been analyzed by a combined ESI MS and X‐ray diffraction (XRD) approach. ESI MS measurements confirmed formation of stable adducts between the intact gold(I) complex and Tel 23 DNA sequence. The crystal structure of the adduct formed between [Au(9‐methylcaffein‐8‐ylidene)2]+ and Tel 23 DNA G‐quadruplex was solved. Tel 23 maintains a characteristic propeller conformation while binding three gold(I) dicarbene moieties at two distinct sites. Stacking interactions appear to drive noncovalent binding of the gold(I) complex. The structural basis for tight gold(I) complex/G‐quadruplex recognition and its selectivity are described.

19 May 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JWJulia Wirmer‐Bartoschek
Julia Wirmer‐Bartoschek
LBLars Erik Bendel
Lars Erik Bendel
HJHendrik R. A. Jonker
Hendrik R. A. Jonker
JGJ. Tassilo Grün
J. Tassilo Grün
FPFrancesco Papi
Francesco Papi
HSHarald Schwalbe
Harald Schwalbe

16 October 2018 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
FGFederica Guarra
Federica Guarra
Tiziano MarzoTiziano Marzo
Tiziano Marzo
MFMarta Ferraroni
Marta Ferraroni
FPFrancesco Papi
Francesco Papi
CBCarla Bazzicalupi
Carla Bazzicalupi
Chiara GabbianiChiara Gabbiani
Chiara Gabbiani
The bis carbene gold(I) complex [Au(1-butyl-3-methyl-2-ylidene)2]PF6, ([Au(NHC)2]PF6 hereafter), holds remarkable interest as a perspective anticancer agent. The compound is stable under physiological like conditions: its original structure is retained even in the presence of excess glutathione (GSH). Previous studies revealed its high cytotoxicity in vitro that correlates with the impairment of crucial metabolic and enzymatic cellular processes (Magherini et al., Oncotarget, 2018, 9, 28042). Here, the interaction of [Au(NHC)2]PF6 with the human telomeric DNA G-quadruplex Tel23 has been investigated in solution by means of high resolution mass spectrometry. ESI MS experiments well document the formation of stable 1 : 1 adducts between the biscarbene gold complex – in its intact form – and the DNA G-quadruplex Tel23. Next, through independent biophysical methods, we show that [Au(NHC)2]PF6 binding does not significantly affect the G quadruplex melting temperature nor its conformation. The crystal structure for the [Au(NHC)2]+/Tel24 adduct was eventually determined by a joint X-ray diffraction and in silico simulation approach. Through the careful integration of solution and solid-state data, a quite clear picture emerges for the interaction of this gold complex with the Tel23 G-quadruplex.

2 May 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
VRVincent H. S. van Rixel
Vincent H. S. van Rixel
ABAnja Busemann
Anja Busemann
MWMathijs F. Wissingh
Mathijs F. Wissingh
SHSamantha L. Hopkins
Samantha L. Hopkins
BSBianka Siewert
Bianka Siewert
SBSylvestre Bonnet
Sylvestre Bonnet
Four‐way junctions (4WJs) are supramolecular DNA assemblies comprising four interacting DNA strands that in biology are involved in DNA‐damage repair. In this study, a new mononuclear platinum(II) complex 1 was prepared that is capable of driving the crystallization of the DNA oligomer 5′‐d(CGTACG)‐3′ specifically into a 4WJ‐like motif. In the crystal structure of the 1–CGTACG adduct, the distorted‐square‐planar platinum complex binds to the core of the 4WJ‐like motif through π–π stacking and hydrogen bonding, without forming any platinum–nitrogen coordination bonds. Our observations suggest that the specific molecular properties of the metal complex are crucially responsible for triggering the selective assembly of this peculiar DNA superstructure.

7 February 2020 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Open access
FPFrancesco Papi
Francesco Papi
CBCarla Bazzicalupi
Carla Bazzicalupi
MFMarta Ferraroni
Marta Ferraroni
GCGiulia Ciolli
Giulia Ciolli
Paolo LombardiPaolo Lombardi
Paolo Lombardi
Paola GratteriPaola Gratteri
Paola Gratteri
Telomerase is an enzyme deputed to the maintenance of eukaryotic chromosomes; however, its overexpression is a recognized hallmark of many cancer forms. A viable route for the inhibition of telomerase in malignant cells is the stabilization of G-quadruplex structures (G4) at the 3′ overhang of telomeres. Berberine has shown in this regard valuable G4 binding properties together with a significant anticancer activity and telomerase inhibition effects. Here, we focused on a berberine derivative featuring a pyridine containing side group at the 13th position. Such modification actually improves the binding toward telomeric G-quadruplexes and establishes a degree of selectivity in the interaction with different sequences. Moreover, the X-ray crystal structure obtained for the complex formed by the ligand and a bimolecular human telomeric quadruplex affords a better understanding of the 13-berberine derivatives behavior with telomeric G4 and allows to draw useful insights for the future design of derivatives with remarkable anticancer properties.

11 February 2016 in Chemistry – An Asian Journal
Verified
Journal Article
Closed access
PDF file
MFMarta Ferraroni
Marta Ferraroni
CBCarla Bazzicalupi
Carla Bazzicalupi
FPFrancesco Papi
Francesco Papi
GFGaetano Fiorillo
Gaetano Fiorillo
LOLuis Miguel Guamán Ortiz
Luis Miguel Guamán Ortiz
Paola GratteriPaola Gratteri
Paola Gratteri